Literature DB >> 15582684

(+)-Methamphetamine-induced spontaneous behavior in rats depends on route of (+)METH administration.

W Brooks Gentry1, Abid U Ghafoor, William D Wessinger, Elizabeth M Laurenzana, Howard P Hendrickson, S Michael Owens.   

Abstract

These studies examined the role of (+)-methamphetamine ((+)METH) administration route on spontaneous behavioral activity vs. time relationships, and pharmacokinetic mechanisms for differences in effects. Male Sprague-Dawley rats (n=6 per administration route) received saline and three doses (0.3, 1.0 and 3.0 mg/kg) of (+)METH in a mixed-sequence design by intravenous (iv), subcutaneous (sc) or intraperitoneal (ip) administration. Locomotion and stereotypy were quantified by video-tracking analysis. The effects of (+)METH on spontaneous behavior were dose- and route-dependent. In particular, total locomotor activity was greatest following 3.0 mg/kg intraperitoneally (P<0.05) and stereotypy ratings were greatest following 3.0 mg/kg subcutaneously (P<0.05). In addition, the duration of locomotor effects was greatest after 3.0 mg/kg subcutaneously (P<0.05). Serum pharmacokinetic parameters were determined in separate rats given 3.0 mg/kg by subcutaneous and intraperitoneal administration (n=4 per administration route). The (+)METH elimination half-life was not different between the routes, but the (+)METH AUC was greater (P<0.05), and the (+)METH and (+)-amphetamine (AMP) maximum concentrations occurred later following subcutaneous than after intraperitoneal dosing (P<0.05), increasing and prolonging drug exposure. In conclusion, the overall pattern of (+)METH effects on locomotor activity depend on dose and the route of administration, which affects serum concentration and the time course of behavioral effects.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15582684     DOI: 10.1016/j.pbb.2004.10.006

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  27 in total

1.  Dopaminergic neuronal injury in the adult rat brain following neonatal exposure to lipopolysaccharide and the silent neurotoxicity.

Authors:  Lir-Wan Fan; Lu-Tai Tien; Baoying Zheng; Yi Pang; Rick C S Lin; Kimberly L Simpson; Tangeng Ma; Philip G Rhodes; Zhengwei Cai
Journal:  Brain Behav Immun       Date:  2010-09-27       Impact factor: 7.217

2.  Sex differences in (+)-amphetamine- and (+)-methamphetamine-induced behavioral response in male and female Sprague-Dawley rats.

Authors:  Alessandra Milesi-Hallé; Donald E McMillan; Elizabeth M Laurenzana; Kelly A Byrnes-Blake; S Michael Owens
Journal:  Pharmacol Biochem Behav       Date:  2007-01-09       Impact factor: 3.533

3.  Chronic treatment of (+)-methamphetamine-induced locomotor effects in rats using one or a combination of two high affinity anti-methamphetamine monoclonal antibodies.

Authors:  Michael D Hambuchen; Daniela Rüedi-Bettschen; Melinda G Gunnell; Howard Hendrickson; S Michael Owens
Journal:  Hum Vaccin Immunother       Date:  2016-05-10       Impact factor: 3.452

4.  Dorsolateral striatal miR-134 modulates excessive methamphetamine intake in self-administering rats.

Authors:  Jing-Jing Shi; Dan-Ni Cao; Hui-Fen Liu; Zhi-Yuan Wang; Guan-Yi Lu; Ning Wu; Wen-Hua Zhou; Jin Li
Journal:  Metab Brain Dis       Date:  2019-06-01       Impact factor: 3.584

5.  Treatment of rats with an anti-(+)-methamphetamine monoclonal antibody shortens the duration of action of repeated (+)-methamphetamine challenges over a one month period.

Authors:  Michael D Hambuchen; Daniela Rüedi-Bettschen; D Keith Williams; Howard Hendrickson; S Michael Owens
Journal:  Vaccine       Date:  2014-09-22       Impact factor: 3.641

6.  A methamphetamine vaccine attenuates methamphetamine-induced disruptions in thermoregulation and activity in rats.

Authors:  Michelle L Miller; Amira Y Moreno; Shawn M Aarde; Kevin M Creehan; Sophia A Vandewater; Brittani D Vaillancourt; M Jerry Wright; Kim D Janda; Michael A Taffe
Journal:  Biol Psychiatry       Date:  2012-10-23       Impact factor: 13.382

7.  A comparison of amphetamine- and methamphetamine-induced locomotor activity in rats: evidence for qualitative differences in behavior.

Authors:  Darien A Hall; Jessica J Stanis; Hector Marquez Avila; Joshua M Gulley
Journal:  Psychopharmacology (Berl)       Date:  2007-09-17       Impact factor: 4.530

8.  Bioavailability of (+)-methamphetamine in the pigeon following an intramuscular dose.

Authors:  Howard P Hendrickson; William C Hardwick; D E McMillan; S Michael Owens
Journal:  Pharmacol Biochem Behav       Date:  2008-03-29       Impact factor: 3.533

9.  Consequences of Oral Gavage during Gestation and Lactation on Rat Dams and the Neurodevelopment and Behavior of Their Offspring.

Authors:  Kate McDonnell-Dowling; Silke Kleefeld; John P Kelly
Journal:  J Am Assoc Lab Anim Sci       Date:  2017-01-01       Impact factor: 1.232

10.  Behavioral, neurochemical and pharmaco-EEG profiles of the psychedelic drug 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in rats.

Authors:  Tomáš Páleníček; Michaela Fujáková; Martin Brunovský; Jiří Horáček; Ingmar Gorman; Marie Balíková; Lukáš Rambousek; Kamila Syslová; Petr Kačer; Petr Zach; Věra Bubeníková-Valešová; Filip Tylš; Anna Kubešová; Jana Puskarčíková; Cyril Höschl
Journal:  Psychopharmacology (Berl)       Date:  2012-07-29       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.